$CRTG
CORETEC GROUP INC.

2016 Q2 Form 10-Q Financial Statement

#000114420417043012 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2016 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin -$160.0K
YoY Change -176.19%
% of Gross Profit
Research & Development $69.45K
YoY Change 2882.01%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $69.45K
YoY Change 2882.01%
Operating Profit
YoY Change
Interest Expense $6.736K
YoY Change -60.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $70.00K
YoY Change -130.43%
Income Tax
% Of Pretax Income
Net Earnings -$108.9K
YoY Change -53.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $13.18K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.00K
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $10.00K
YoY Change 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.00K
YoY Change 100.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $4.245K
YoY Change -40.34%
TOTAL ASSETS
Total Short-Term Assets $20.00K
Total Long-Term Assets $4.245K
Total Assets $24.25K
YoY Change 41.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $368.9K
YoY Change -24.75%
Accrued Expenses $110.0K
YoY Change -62.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due -$64.13K
YoY Change -120.04%
Total Short-Term Liabilities $563.8K
YoY Change -49.12%
LONG-TERM LIABILITIES
Long-Term Debt $75.00K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $75.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $563.8K
Total Long-Term Liabilities $75.00K
Total Liabilities $638.8K
YoY Change -42.35%
SHAREHOLDERS EQUITY
Retained Earnings -$22.61M
YoY Change
Common Stock $21.99M
YoY Change 6.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$614.5K
YoY Change
Total Liabilities & Shareholders Equity $24.25K
YoY Change 41.66%

Cashflow Statement

Concept 2016 Q2
OPERATING ACTIVITIES
Net Income -$108.9K
YoY Change -53.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$120.0K
YoY Change 500.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 130.0K
YoY Change 550.0%
NET CHANGE
Cash From Operating Activities -120.0K
Cash From Investing Activities
Cash From Financing Activities 130.0K
Net Change In Cash 10.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$120.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
82199 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
260807 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64381 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
596820 USD
us-gaap Net Income Loss
NetIncomeLoss
-157887 USD
us-gaap Net Income Loss
NetIncomeLoss
-981290 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Sales Revenue Net
SalesRevenueNet
0 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4939182 shares
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69451 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
155437 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32665 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
315489 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-108852 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-457459 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-148831 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
461956 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
155520 USD
CY2016Q2 us-gaap Cash
Cash
500 USD
us-gaap Depreciation
Depreciation
558 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
486750 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
155520 USD
us-gaap Interest Paid
InterestPaid
626 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
24794 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46782 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
556 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
34200 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2017Q2 crtg Working Capital Deficit
WorkingCapitalDeficit
2053412 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
103428981 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41842241 shares
CY2016Q4 crtg Product Scaleup And Manufacturing Optimization Cost
ProductScaleupAndManufacturingOptimizationCost
180000 USD
CY2016Q4 crtg Product Scaleup And Manufacturing Optimization Cost First Installment
ProductScaleupAndManufacturingOptimizationCostFirstInstallment
18000 USD
CY2016Q4 crtg Product Scaleup And Manufacturing Optimization Cost Second Installment
ProductScaleupAndManufacturingOptimizationCostSecondInstallment
162000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
19500 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
14936 USD
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4939182 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4939182 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4939182 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4939182 shares
CY2017Q2 us-gaap Interest Expense
InterestExpense
81497 USD
CY2016Q2 us-gaap Interest Expense
InterestExpense
6736 USD
us-gaap Interest Expense
InterestExpense
123663 USD
us-gaap Interest Expense
InterestExpense
11307 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
552423 USD
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
108852 USD
us-gaap Costs And Expenses
CostsAndExpenses
981290 USD
us-gaap Costs And Expenses
CostsAndExpenses
157887 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2268 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
232 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15000 USD
crtg Repayment Ofadvances To Notes Receivable From Related Parties
RepaymentOfadvancesToNotesReceivableFromRelatedParties
0 USD
crtg Repayment Ofadvances To Notes Receivable From Related Parties
RepaymentOfadvancesToNotesReceivableFromRelatedParties
5000 USD
CY2016Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-559476 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-851158 USD
CY2016Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0 USD
CY2017Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1191075 USD
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2017Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
25000 USD
CY2016Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0 USD
CY2017Q2 crtg Accrued Interest Payable Related Parties Current
AccruedInterestPayableRelatedPartiesCurrent
19146 USD
CY2016Q4 crtg Accrued Interest Payable Related Parties Current
AccruedInterestPayableRelatedPartiesCurrent
71309 USD
crtg Options To Issue Common Stock
OptionsToIssueCommonStock
50000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3259 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2500 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2017Q2 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
150000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
350000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
50000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000 USD
CY2017Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one for 300
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
50000 USD
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
2.6052 pure
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0184 pure
CY2017Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1225275 USD
CY2016Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1054325 USD

Files In Submission

Name View Source Status
0001144204-17-043012-index-headers.html Edgar Link pending
0001144204-17-043012-index.html Edgar Link pending
0001144204-17-043012.txt Edgar Link pending
0001144204-17-043012-xbrl.zip Edgar Link pending
crtg-20170630.xml Edgar Link completed
crtg-20170630.xsd Edgar Link pending
crtg-20170630_cal.xml Edgar Link unprocessable
crtg-20170630_def.xml Edgar Link unprocessable
crtg-20170630_lab.xml Edgar Link unprocessable
crtg-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472865_10q.htm Edgar Link pending
v472865_ex31-1.htm Edgar Link pending
v472865_ex31-2.htm Edgar Link pending
v472865_ex32-1.htm Edgar Link pending
v472865_ex32-2.htm Edgar Link pending